newsfilter
← Latest News
ACCESS Newswire·

Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements

ZURICH, SWITZERLAND / ACCESSWIRE / June 25, 2024 / NLS Pharmaceutics Ltd. , a leading Swiss biopharmaceutical company dedicated to pioneering